Loading Complete
Petros Constantine Karakousis

Petros Constantine Karakousis, MD

Infectious Diseases

Johns Hopkins Affiliations:
  • Johns Hopkins School of Medicine Faculty

Languages

  • Russian
  • German
  • Spanish
  • Greek
  • English

14 Insurances Accepted

View all

Gender

Male

About Petros Constantine Karakousis

Primary Academic Title

Professor of Medicine

Background

Dr. Petros Karakousis is an associate professor of medicine at the Johns Hopkins University School of Medicine. He has a joint appointment in international health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis. 

Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005. 

His research interests include Mycobacterium tuberculosis latency and persistence.

Dr. Karakousis is a board member for the Hopkins Hellenic Initiative. He serves as an academic editor for PLoS One and is on the editorial advisory board of the Journal of Infectious Diseases. He is a member of the American Thoracic Society, the American Society for Microbiology, the Infectious Disease Society of America and the American College of Physicians.

Centers and Institutes

Heart and Vascular Institute

Contact for Research Inquiries

1551 E. Jefferson Street, Rm 110
Baltimore, MD 21287-0014

Phone: (410) 502-8233
petros@jhmi.edu

Research Interests

Mycobacterium tuberculosis latency and persistence

Lab Website

Karakousis Lab - Lab Website

  • The primary focus of the Karakousis Lab is to understand the molecular basis of Mycobacterium tuberculosis latency and reactivation. 

    Major research activities include studying the adaptation of M. tuberculosis to stress conditions believed to be important in the infected human host, as well as the phenomenon of phenotypic tolerance to antibiotics. In particular, the regulatory cascade involved in the mycobacterial stringent response is under active investigation. A systems biology-based approach is being used to identify host cytokine networks responsible for immunological control of M. tuberculosis growth, as well as M. tuberculosis regulatory and metabolic pathways required for bacillary growth restriction and reactivation.

    The laboratory is also actively involved in preclinical drug screening in physiologically relevant animal models. 

    A third focus of the laboratory is the development of novel molecular assays for the rapid diagnosis of latent TB infection and active TB disease, and for the detection of drug resistance. Specifically, molecular assays using blood, sputum, and urine samples are being investigated with the goal of developing rapid, sensitive and specific point-of-care tests for TB diagnosis and detection of drug resistance.

Research Summary

Dr. Karakousis’ primary research interest is the molecular basis of Mycobacterium tuberculosis latency and reactivation. Secondary interests include preclinical screening of novel TB drugs and drug combinations in animal models of caseous necrosis, as well as development of novel molecular assays for the rapid diagnosis of latent TB infection and active TB disease, and for the detection of drug resistance.

Selected Publications

  • Chuang Y-M, Bandyopadhyay N, Rifat D, Rubin H, Bader JS, Karakousis PC. “Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis.” mBio. 2015;6(2).

  • Levine DM, Dutta NK, Eckels J, Scanga C, Stein C, Mehra S, Kaushal D, Karakousis PC, Salamon H. “A tuberculosis ontology for host systems biology.” Tuberculosis. 2015;95(5):570-574.

  • Subbian S, Tsenova L, Kim M-J,  Wainwright HC, Visser A, Bandyopadhyay N, Bader JS, Karakousis PC, Murrmann GB, Bekker LG, et al. “Lesion-specific immune response in granulomas of patients with pulmonary tuberculosis: A pilot study.” PLoS ONE. 2015;10(7).

  • Xu Z, Zhou A, Ni J, Zhang Q, Wang Y, Lu J, Wu W, Karakousis PC, Lu S, Yao Y. “Differential expression of miRNAs and their relation to active tuberculosis.” Tuberculosis. 2015;95(4):395-403.

  • Zhou A, Ni J, Xu Z,  Wang Y, Zhang H, Wu W, Lu S, Karakousis PC, Yao Y-F.  “Metabolomics specificity of tuberculosis plasma revealed by 1(H) NMR spectroscopy.” Tuberculosis. 2015;95(3):294-302.

Honors

  • Fellow, Infectious Diseases Society of America, 1/1/10
  • Basic Research Junior Faculty Award, Johns Hopkins, 1/1/09
  • Basic Research Junior Faculty Award Finalist, Johns Hopkins, 1/1/08
  • Arthur M. Dannenberg, Jr. Award for Postdoctoral Research, 1/1/05
  • Best Abstract, Assembly of Microbiology, Tuberculosis, and Pulmonary Infections, American Thoracic Society Annual Meeting, 1/1/04
  • Travel Grant to ATS Annual Meeting, American Thoracic Society, 1/1/04
  • Basic Research Postdoctoral Fellow Award Nominee, Johns Hopkins, 1/1/04

Graduate Program Affiliations

  • Graduate Program in Pathobiology

Memberships

  • American Thoracic Society
  • American Society for Microbiology
  • Infectious Disease Society of America
  • American College of Physicians

Professional Activities

  • Johns Hopkins University-University of Patras, Greece, Hopkins Hellenic Initiative Board Member, 5/1/07
  • Journal of Infectious Diseases, Editorial Advisory Board, 5/1/13
  • Office of Faculty Development, Senior Advisory Council, 1/1/14
  • PLoS One, Academic Editor, 9/1/11
  • Reappointment Review Committee, Instructor/Assistant Professor, 5/1/14

Locations

  1. The Johns Hopkins Hospital
    • 1800 Orleans Street, Baltimore, MD 21287

    Expertise

    Education

    Johns Hopkins University School of Medicine

    Fellowship, Infectious Diseases, 2005

    Penn Medicine University of Pennsylvania

    Residency, Internal Medicine, 2001

    Washington University School of Medicine

    Medical Education, MD, 1998

    Board Certifications

    Infectious Disease

    American Board of Internal Medicine, 2005

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)